Sign in Create account

Vijaya Diagnostic Centre Limited

Healthcare · Healthcare Services

NSE: VIJAYA BSE: 543350
₹1437.70
▼ -37.30 (-2.53%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
84/100
Strong
Valuation
16/100
Expensive
Momentum
31/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹14,807 Cr
PE (TTM)
76.7
Industry median 50.2 (44 companies)
Price to Book
15.5
PEG (TTM)
2.3
Institutions holding %
43.23%
FII + DII, latest filed period
Piotroski Score
7
Relative return vs Nifty50, qtr %
12.4
Relative return vs Sector, qtr %
7.7
Free Cash Flow
₹88 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
38.24%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
9.86%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
22.39%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
8.11%
as of Sept. 30, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
24.99%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
2.60
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
8.44
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
22.55%
as of Sept. 30, 2025
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
37.22%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
35.87%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
11.48%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
19.22%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
18.07%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

7 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 7)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (18.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (2.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.5%
Low 1435.0000 · High 1490.0000
1W return
-8.5%
Low 1435.0000 · High 1571.4000
1M return
-5.3%
Low 1380.0000 · High 1593.6000
52W return
43.2%
Low 848.0000 · High 1593.6000
Lifetime High ₹1570.7000 (Sept. 23, 2026)
Lifetime Low ₹300.4000 (June 14, 2022)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
1481.9
10D
1496.0
20D
1495.6
50D
1456.0
100D
1373.1
200D
1192.9

Delivery and volume

Day avg. delivery
57.9%
Week avg. delivery
55.3%
Month avg. delivery
41.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1454.23
Pivot
First resistance1473.47
Second resistance1509.23
Third resistance1528.47
First support1418.47
Second support1399.23
Third support1363.47
Day RSI42.3
Day MFI44.3
Day MACD7.55
Day MACD signal17.28

Beta

1M1.97
3M0.67
1Y0.52
3Y0.49

Price change analysis

↓ -5.3%
Over 1 Month
LowHigh
1380.001593.60
↑ 4.9%
Over 3 Months
LowHigh
1291.001593.60
↑ 62.5%
Over 6 Months
LowHigh
852.601593.60
↑ 43.2%
Over 1 Year
LowHigh
848.001593.60
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 76.7 (own history: 49.8–81.9)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹219 Cr
Net profit (June 30, 2026)
₹53 Cr
Basic EPS (June 30, 2026)
₹5.1700

Ranks #10 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.47%
  • Mutual funds30.63%
  • FII/FPI11.65%
  • Other DII0.95%
  • Public4.30%

Largest holders

NameCategoryShares %Shares
SURENDRANATH REDDY SURAPromoter32.2000%33166309
SUPRITA SURA REDDYPromoter8.7100%8971660
SUNIL CHANDRA KONDAPALLYPromoter7.5500%7775843
KOTAK SMALL CAP FUNDPublic6.5900%6783997
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MULPublic5.6400%5807259

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 52.51% to 52.47% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 13.38% to 11.65% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 29.06% to 30.63% in Jun 2026 qtr

23 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 9 insider trades, 18 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
1 Apr 2023 Damodar Chinchod Reddy Immediate relative Sell 0 ₹0
28 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
24 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0
23 Jun 2022 Sura Surendranath Reddy Promoter Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 38 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
8 Apr 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 1,170,344 983.5100 NSE
8 Apr 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 1,170,344 983.6900 NSE
4 Mar 2025 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 523,967 1024.3500 NSE
4 Mar 2025 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 523,967 1023.8800 NSE
4 Mar 2025 HRTI PRIVATE LIMITED Bulk Buy 814,594 1019.3000 NSE
4 Mar 2025 HRTI PRIVATE LIMITED Bulk Sell 769,580 1020.5200 NSE
4 Mar 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 1,180,400 1029.0600 NSE
4 Mar 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 1,180,400 1029.5300 NSE
27 Feb 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 598,243 975.7200 NSE
27 Feb 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 598,243 977.1000 NSE

All bulk and block deals →

Dividends

Full dividend history →
Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 2.0000 — —
29 Aug 2025 Dividend - Rs 2 Per Share 2.0000 29 Aug 2025
30 Aug 2024 Dividend - Re 1 Per Share 1.0000 30 Aug 2024
13 Sep 2023 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 13 Sep 2023
20 Sep 2022 Dividend - Re 1 Per Share 1.0000 21 Sep 2022

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
6 Aug 2026 Financial Results/Other business matters Yes
7 May 2026 Financial Results/Dividend/Other business matters Yes
13 Feb 2026 Financial Results Yes
4 Nov 2025 Financial Results Yes
28 Jul 2025 Financial Results Yes

Corporate Announcements

All 462 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Vijaya Diagnostic Centre Ltd - 543350 - Closure of Trading Window
28 Sep 2026 Trading Window Vijaya Diagnostic Centre Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
26 Sep 2026 Shareholders meeting Vijaya Diagnostic Centre Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
24 Sep 2026 Shareholders meeting Vijaya Diagnostic Centre Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
11 Sep 2026 Company Update Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor Presentation
11 Sep 2026 Company Update Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
11 Sep 2026 Others Vijaya Diagnostic Centre Ltd - 543350 - Board Meeting Outcome for Outcome Of The Board Meeting - Acquisition
11 Sep 2026 General Updates Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates - Investor Presentation - 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
11 Sep 2026 Press Release Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.".
11 Sep 2026 Outcome of Board Meeting Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (22.6%)
  • Low financial leverage (Debt/Equity 0.00)
  • Healthy liquidity (Current Ratio 2.60)
  • Strong revenue growth YoY (25.0%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (76.7) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Vijaya Diagnostic Centre Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.